ALNT Stock Analysis: Allient | NASDAQ
Electronic Components | NASDAQ, USA | Market Cap: 1.690m USD | 12M Return: 100.2% | US0193301092 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 27.3M
EPS Trend: 0.2%
Qual. Beats: 1
Rev. Trend: -29.9%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Allient Inc. (NASDAQ: ALNT) designs, manufactures, and sells precision and specialty motion control components and systems, serving industrial, vehicle, medical, and aerospace and defense end markets across the Americas, Europe, and Asia-Pacific. Its product portfolio spans servo systems, motion controllers, brushless and brush motors, encoders, motor-drives, gear motors, and power quality filters, distributed through direct sales, manufacturers representatives, and distributors.
The company operates within the Industrials sector (GICS Sub-Industry: Electrical Components & Equipment), a segment positioned to benefit from broader trends in industrial automation, factory electrification, and demand for higher precision in medical and aerospace applications. Headquartered in Amherst, New York, Allient was founded in 1939 and rebranded from Allied Motion Technologies to Allient Inc. in August 2023.
- Aerospace and defense segment revenue grows on rising government spending
- Industrial automation demand drives motion control product sales
- M&A strategy expands portfolio and geographic footprint
| Net Income: 28.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -4.78 > 1.0 |
| NWC/Revenue: 33.80% < 20% (prev 35.82%; Δ -2.02% < -1%) |
| CFO/TA 0.06 > 3% & CFO 38.4m > Net Income 28.6m |
| Net Debt (186.7m) to EBITDA (79.8m): 2.34 < 3 |
| Current Ratio: 3.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.9m) vs 12m ago 0.97% < -2% |
| Gross Margin: 32.24% > 18% (prev 31.49%; Δ 0.75% > 0.5%) |
| Asset Turnover: 97.26% > 50% (prev 88.36%; Δ 8.90% > 0%) |
| Interest Coverage Ratio: 3.08 > 6 (EBIT TTM 54.7m / Interest Expense TTM 17.7m) |
| A: 0.33 (Total Current Assets 274.4m - Total Current Liabilities 80.2m) / Total Assets 593.9m |
| B: 0.36 (Retained Earnings 211.6m / Total Assets 593.9m) |
| C: 0.09 (EBIT TTM 54.7m / Avg Total Assets 591.0m) |
| D: 1.11 (Book Value of Equity 312.3m / Total Liabilities 281.6m) |
| Altman-Z'' = 5.09 = AAA |
| DSRI: 1.06 (Receivables 99.8m/84.9m, Revenue 574.8m/519.6m) |
| GMI: 0.98 (GM 31.49% / 32.24%) |
| AQI: 0.94 (AQ_t 0.39 / AQ_t-1 0.42) |
| SGI: 1.11 (Revenue 574.8m / 519.6m) |
| TATA: -0.02 (NI 28.6m - CFO 38.4m) / TA 593.9m) |
| Beneish M = -2.96 (Cap -4..+1) = A |
As of August 25, 2026, the stock is trading at USD 93.08 with a total of 145,632 shares traded. Over the past week, the price has changed by -17.61%, over one month by +7.30%, over three months by +30.56% and over the past year by +100.20%.
Current recommended Stop Loss: 85.70 (which is 7.9% or 1.2 ATR below the current price).
Allient has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy ALNT.
- StrongBuy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 118 | 26.8% |
P/E Trailing = 59.8976
P/E Forward = 35.8423
P/S = 2.9412
P/B = 5.5386
Revenue TTM = 574.8m USD
EBIT TTM = 54.7m USD
EBITDA TTM = 79.8m USD
Long Term Debt = 165.9m USD (from longTermDebt, last quarter)
Short Term Debt = 5.49m USD (from shortTermDebt, last quarter)
Debt = 228.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 31.7m
Net Debt = 186.7m USD (calculated: Debt 228.8m - CCE 42.1m)
Enterprise Value = 1.88b USD (1.69b + Debt 228.8m - CCE 42.1m)
Interest Coverage Ratio = 3.08 (Ebit TTM 54.7m / Interest Expense TTM 17.7m)
EV/FCF = 68.25x (Enterprise Value 1.88b / FCF TTM 27.5m)
FCF Yield = 1.47% (FCF TTM 27.5m / Enterprise Value 1.88b)
FCF Margin = 4.78% (FCF TTM 27.5m / Revenue TTM 574.8m)
Net Margin = 4.98% (Net Income TTM 28.6m / Revenue TTM 574.8m)
Gross Margin = 32.24% ((Revenue TTM 574.8m - Cost of Revenue TTM 389.5m) / Revenue TTM)
Gross Margin QoQ = 34.85% (prev 30.42%)
Tobins Q-Ratio = 3.16 (Enterprise Value 1.88b / Total Assets 593.9m)
Interest Expense / Debt = 7.76% (Interest Expense 17.7m / Debt 228.8m)
Taxrate = 22.21% (8.17m / 36.8m)
NOPAT = 42.5m (EBIT 54.7m * (1 - 22.21%))
Current Ratio = 3.42 (Total Current Assets 274.4m / Total Current Liabilities 80.2m)
Debt / Equity = 0.73 (Debt 228.8m / totalStockholderEquity, last quarter 312.3m)
Debt / EBITDA = 2.34 (Net Debt 186.7m / EBITDA 79.8m)
Debt / FCF = 6.79 (Net Debt 186.7m / FCF TTM 27.5m)
Total Stockholder Equity = 303.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.84% (Net Income 28.6m / Total Assets 593.9m)
RoE = 9.43% (Net Income TTM 28.6m / Total Stockholder Equity 303.5m)
RoCE = 11.64% (EBIT 54.7m / Capital Employed (Equity 303.5m + L.T.Debt 165.9m))
RoIC = 8.67% (NOPAT 42.5m / Invested Capital 490.5m)
WACC = 13.31% (E(1.69b)/V(1.92b) * Re(14.29%) + D(228.8m)/V(1.92b) * Rd(7.76%) * (1-Tc(0.22)))
Discount Rate = 14.29% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 98.25 | Cagr: 1.01%
[DCF] Terminal Value 57.02% ; FCFF base≈38.6m ; Y1≈33.9m ; Y5≈27.4m
[DCF] Fair Price = 3.36 (EV 243.9m - Net Debt 186.7m = Equity 57.2m / Shares 17.0m; r=13.31% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 0.16 | EPS CAGR: 0.03% | SUE: 2.11 | # QB: 1
Revenue Correlation: -29.95 | Revenue CAGR: -1.39% | SUE: 2.14 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.73 | Chg30d=+1.49% | Revisions=+29% | Analysts=5
EPS current Year (2026-12-31): EPS=2.73 | Chg30d=+8.10% | Revisions=+62% | GrowthEPS=+25.8% | GrowthRev=+8.4%
EPS next Year (2027-12-31): EPS=3.32 | Chg30d=+7.23% | Revisions=+62% | GrowthEPS=+21.6% | GrowthRev=+8.7%
[Analyst] Revisions Ratio: +71% (up=13, down=1)